BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 06/30/2015

Position Statistics

Total Positions 95
New Positions 16
Increased Positions 42
Decreased Positions 26
Positions with Activity 68
Sold Out Positions 7
Total Mkt Value (in $ millions) 1,397

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.99%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 0%
Healthcare 77.75%
Services
Technology 1.66%
Transportation
Utilities

16 New Positions as of 06/30/2015

Company Class Value of Shares ($1,000s) ▲ Change in Value ($1,000s) Change (%) Shares Held
TRIVASCULAR TECHNOLOGIES INC COM 26 26 New 6,032
MEDIWOUND LTD ORD SHS 834 834 New 119,868
CIDARA THERAPEUTICS INC COM 2,139 2,139 New 150,000
RITTER PHARMACEUTICALS INC COM 2,396 2,396 New 778,000
COLLEGIUM PHARMACEUTICAL INC COM 4,485 4,485 New 297,200
EGALET CORP COM 4,500 4,500 New 434,750
SCYNEXIS INC COM 5,518 5,518 New 775,000
VERACYTE INC COM 6,074 6,074 New 736,196
CARBYLAN THERAPEUTICS INC COM 6,319 6,319 New 1,178,941
CONTRAFECT CORP COM 7,177 7,177 New 1,418,440
ABIOMED INC COM 9,729 9,729 New 100,000
ARDELYX INC COM 11,492 11,492 New 649,290
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR 14,305 14,305 New 878,117
KEMPHARM INC COM 15,819 15,819 New 827,810
RAPTOR PHARMACEUTICAL CORP COM 16,459 16,459 New 1,319,883
NEVRO CORP COM 17,097 17,097 New 419,559